Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-complex protein 11-like protein 2 is encoded by the TCP11L2 gene. It is a cytoplasmic protein with uncertain and emerging biological roles. In humans, it is predicted to promote migration of muscle-derived satellite cells—important for muscle regeneration—likely through interactions with FMNL2 and involvement in microfilament assembly[2][5][9]. Its molecular classification does not fit classic categories such as enzyme or receptor; instead, it is a protein with suggested roles in the cytoskeleton and possibly signal transduction[2][5][9]. TCP11L2 is a paralog of TCP11 (with established testis-specific, fertility-related functions in mouse), but TCP11L2 itself has a broader tissue expression pattern and lacks direct evidence for involvement in specific human diseases or drug interactions at this time[3][2]. It contains the TCP11 conserved protein domain, whose biochemical function remains to be fully characterized[3]. No current safety concerns, biomarkers, or drug mechanisms of action are documented for this protein[2][5][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-complex protein 11-like protein 2 (TCP11L2).